Showing 831-840 of 1161 results for "".
- Oculis Announces Appointment of Leading Ophthalmology Specialists to Scientific Advisory Boardhttps://modernod.com/news/oculis-announces-appointment-of-leading-ophthalmology-specialists-to-scientific-advisory-board/2476888/Oculis SA announced the appointments of Eric Donnenfeld, MD, and Pr. Ramin Tadayoni, MD, PhD, to its Scientific Advisory Board (SAB). “I am pleased to welcome Eric and Ramin to our SAB and look forward to their contributions as we focus on our objective of developing topical medicines that
- National Cancer Institute Director Ned Sharpless to Become Acting FDA Headhttps://modernod.com/news/national-cancer-institute-director-ned-sharpless-to-cecome-acting-fda-head/2476373/Ned Sharpless, MD, the current director of the US National Cancer Institute (NCI), will assume the position of acting chief of the FDA when Scott Gottlieb, MD, steps down next month. Dr. Gottlieb, who recently tendered his resignation from the role, is said to have recommended Dr. Sharpless for t
- The ASCRS Announces 2019 Ophthalmology Hall of Fame Inducteeshttps://modernod.com/news/the-ascrs-announces-2019-ophthalmology-hall-of-fame-inductees/2476313/The American Society of Cataract and Refractive Surgery (ASCRS) has announced that it will induct Howard V. Gimbel, MD, MPH, FRCSC, FACS and the late Phillips Thygeson, MD into the ASCRS Ophthalmology Hall of Fame on Saturday, May 4, 2019, according to a
- Statement From FDA Leadership On a Record Year for Device Innovationhttps://modernod.com/news/statement-from-fda-leadership-on-a-record-year-for-device-innovation/2479598/FDA Commissioner Scott Gottlieb, MD, and Jeff Shuren, MD, director for the Center for Devices and Radiological Health, released the following statement addressing a record year for device innovation: “The FDA’s focus on both safety and innovation stems from our historic mission
- Spark Therapeutics Gene Therapy Pioneers Win $1 Million Sanford Lorraine Cross Awardhttps://modernod.com/news/spark-therapeutics-gene-therapy-pioneers-win-1-million-sanford-lorraine-cross-award/2476159/Two women with a vision to make the blind see were the winners of the inaugural $1 million Sanford Lorraine Cross Award. Jean Bennett, MD, PhD, and Katherine A. High, MD, whose work with the RPE65 mutation has reversed an inherited form of blindness, accepted the award on December 4 at Sanford He
- Santen Expands Research and Development Leadership Teamhttps://modernod.com/news/santen-expands-research-and-development-leadership-team/2479666/Santen announced the expansion of its research and development leadership team through the addition of two new executive hires. Reza M. Haque, MD, PhD, has been appointed as Senior Vice President, Global Research and Development Strategy, and Peter Sallstig, MD, MBA
- Bio-Tissue Highlights Publication of DREAM Studyhttps://modernod.com/news/bio-tissue-highlights-publication-of-dream-study/2480079/Bio-Tissue highlighted the publication of the Dry Eye Amniotic Membrane (DREAM) study in Clinical Ophthalmology.[1] This retrospective study was conducted at 10 clinical sites in the United States, led by Marguerite McDonald, MD, and Hosam Sheha, MD. It demonstrates that a single applica
- Sight Sciences Announces Publication of Historical Review of Canal Surgeryhttps://modernod.com/news/sight-sciences-announces-publication-of-historical-review-of-canal-surgery/2477484/Sight Sciences announced that a review of the history of canal surgery in glaucoma, by Jaime Dickerson, PhD, and Reay Brown, MD, has been published in
- Kowa Initiates Phase 3 Safety Trial for Glaucoma Drug Candidate NCX 470 in Japanhttps://modernod.com/news/kowa-initiates-phase-3-safety-trial-for-glaucoma-drug-candidate-ncx-470-in-japan/2482918/Nicox announced that its exclusive Japanese partner, Kowa, has officially initiated a phase 3 safety clinical trial for NCX 470 (also referred to as K-911) in Japan. NCX 470 is Nicox’s lead clinical candidate, currently undergoing phase 3 clinical evaluations
- Oculus Launches Myopia Software Package on the Pentacam AXL Wavehttps://modernod.com/news/oculus-launches-myopia-software-package-on-the-pentacam-axl-wave/2482670/Oculus is launching the Myopia Software Package on the Pentacam AXL Wave. The new software is designed to offer optometrists improved accuracy, ease, and safety in their myopia management, comprehensive screening, and ortho-k fitting with one device. The Pentacam AXL